Your business opportunities

Your business opportunities


Medicon Valley is the place to develop your business. The region has a long tradition within biotech and constitutes a fully integrated biotech cluster.

In Medicon Valley there are more than 100 biotech companies with own R&D, major R&D based pharmaceutical companies, more than 200 medtech companies, more than 50 relevant service providers, CRO´s and CMO´s and a dozen experienced life science VC´s - all varying in size and specialization.


> TAKE A CLOSER LOOK



Welcome to the official website of Medicon Valley

Welcome to the official website of Medicon Valley


This website is brought to you by the organisations, Invest in Skåne (Sweden) and Copenhagen Capacity (Denmark). Here you will find information about your business opportunities in Medicon Valley.

We will guide you through your search for R&D partners, new technologies, investment options or help you establishing a legal entity for maximizing your business opportunities.

We have in-depth knowledge of the biotech-, pharmaceutical- and medtech industries, company pipelines and partnering opportunities in Medicon Valley.


> SEE HOW WE CAN HELP YOU



CellaVision to apply for listing on NASDAQ

> PRINT THIS PAGE
   SHARE
Jan. 11, 2010

The Board of Directors of CellaVision AB plans to apply for a listing on NASDAQ OMX Stockholm, Small Cap.
The listing will increase opportunities for institutional investors to invest in CellaVision and create
better share liquidity. The Board expects the listing on NASDAQ OMX Stockholm, Small Cap to take place
during the first half of 2010.

"CellaVision is a sound and stable company with a good business platform making it well-positioned to be
listed on NASDAQ OMX Stockholm's Small Cap. A listing in the main market will improve opportunities to
significantly broaden our investor base, increase liquidity and allow us greater freedom of action in our
continued expansion", says Lars Gatenbeck, Chairman of the Board of CellaVision.

CellaVision's shares have been traded on First North, in the Premier segment, since May 28, 2007. Shares
will continue to be traded on First North Premier until the change to NASDAQ OMX Stockholm, Small Cap has
taken place.

About CellaVision
CellaVision AB develops, markets, and sells market leading image analysis based systems for routine analysis
of blood and other body fluids. The company has a core competence in development of software and hardware
for automatic image analysis of cells and cell changes for applications in health and medical care. The
company develops and markets systems for automatic differentials of white blood cells and red morphology,
and software for education and quality assurance of differentials. The company's associates have expertise
in advanced imaging analysis, artificial intelligence, and automated microscopy.

The company headquarters are in Lund, Sweden. The company also has subsidiaries in USA, Canada and Japan.

For more information, please contact:
Yvonne Mårtensson, CEO
Tel: +46 708 33 77 82
E-mail: yvonne.martensson@cellavision.com

Or visit www.cellavision.com